methotrexate has been researched along with Erythroderma, Sezary in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| de Aquino, IG; Lopes, MA; Rodrigues-Fernandes, CI; Santos-Silva, AR; Vargas, PA | 1 |
| Briones, J; Espeso, M; Martín, A; Mozos, A; Novelli, S; Sánchez, JJ | 1 |
| Alenezi, F; Bessis, D; Dereure, O; Du-Thanh, A; Girard, C; Guillot, B | 1 |
| Cieza-Díaz, DE; Córdoba, R; Machan, S; Prieto-Torres, L; Requena, L | 1 |
| Duvic, M; Seyfer, SJ | 1 |
| Bagot, M; Beylot-Barry, M; Crickx, B; Deschamps, L; Fite, C; Henn, A; Ingen-Housz-Oro, S; Laroche, L; Marinho, E; Maubec, E; Michel, L; Ortonne, N | 1 |
| Chosidow, O; Cordel, N; Delfau, MH; Do-Pham, G; Haioun, C; Ingen-Housz-Oro, S; Moroch, J; Ortonne, N | 1 |
| Beylot-Barry, M; Fauconneau, A; Jullie, ML; Mermin, D; Pham-Ledard, A; Védie, AL | 1 |
| Arulogun, S; Eaton, E; Gambell, P; Lade, S; McCormack, C; Prince, HM; Ryan, G | 1 |
| Curry, JL; Diwan, AH; Duvic, M; Jones, DM; Prieto, VG; Vega, F | 1 |
| Acholonu, S; Champlin, R; Dabaja, B; Donato, M; Duvic, M; Hosing, C; Khouri, I; Richmond, H; Singh, L; Wei, W | 1 |
| Advani, R; Cacchio, P; Demierre, MF; Duvic, M; Foss, F; Junkins-Hopkins, JM; Kim, EJ; Kim, Y; Olsen, EA; Parker, S; Pinter-Brown, L; Pittelkow, M; Porcu, P; Querfeld, C; Rook, AH; Wilson, LD; Wood, G; Zic, J | 1 |
| Furue, M; Hayashida, S; Moroi, Y; Takahara, M; Uchi, H | 1 |
| Lade, S; McCormack, C; Prince, HM; Rodrigues, M; Westerman, D | 1 |
| Allard, A; Bachelez, H; Dauendorffer, JN; Rivet, J | 1 |
| Avilés, A; Castañeda, C; Cleto, S; Gonzalez, M; Huerta-Guzmán, J; Nambo, MJ; Neri, N | 1 |
| Bagot, M | 1 |
| Alper, JC; McDonald, CJ; Schappell, DL | 1 |
| Bauer, R; Böhm, J; Pakos, E; Schupp, G | 1 |
| Hirayama, Y; Koyama, R; Matsunaga, T; Nagai, T; Niitsu, Y; Ohta, H; Sakamaki, S | 1 |
| Epstein, EH; Zackheim, HS | 1 |
2 review(s) available for methotrexate and Erythroderma, Sezary
| Article | Year |
|---|---|
Sézary syndrome: Report of a rare case with perioral manifestation and review of the literature.
Topics: Adrenal Cortex Hormones; Doxepin; Female; Folic Acid; Humans; Lymphadenopathy; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography; Sezary Syndrome; Skin Neoplasms | 2022 |
Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).
Topics: Alkylating Agents; Antibodies, Monoclonal; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Evidence-Based Medicine; Histone Deacetylase Inhibitors; Humans; Immunologic Factors; Methotrexate; Mycosis Fungoides; Quality of Life; Retinoids; Sezary Syndrome; Skin Neoplasms | 2011 |
3 trial(s) available for methotrexate and Erythroderma, Sezary
| Article | Year |
|---|---|
Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Disease Progression; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Melphalan; Methotrexate; Middle Aged; Mycosis Fungoides; Myeloablative Agonists; Recurrence; Sezary Syndrome; Tacrolimus; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation; Young Adult | 2010 |
Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides/Sézary syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Recombinant Proteins; Recurrence; Sezary Syndrome; Skin Neoplasms; Survival Analysis; Treatment Outcome | 2007 |
Treatment of advanced mycosis fungoides and Sézary syndrome with continuous infusions of methotrexate followed by fluorouracil and leucovorin rescue.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Methotrexate; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Neoplasms, Multiple Primary; Sezary Syndrome; Skin Neoplasms; Survival Rate | 1995 |
16 other study(ies) available for methotrexate and Erythroderma, Sezary
| Article | Year |
|---|---|
Management experience of advanced-stage mycosis fungoides/Sézary syndrome: a retrospective study from Spanish haematology referral units.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Palliative Care; Prednisone; Referral and Consultation; Retrospective Studies; Sezary Syndrome; Skin Neoplasms; Spain; Survival Analysis; Transplantation, Homologous; Vincristine | 2020 |
Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome.
Topics: Humans; Methotrexate; Mycosis Fungoides; Odds Ratio; Retrospective Studies; Sezary Syndrome; Skin Neoplasms | 2021 |
Romidepsin in combination with low-dose methotrexate in advanced-stage mycosis fungoides and Sézary syndrome.
Topics: Depsipeptides; Humans; Methotrexate; Mycosis Fungoides; Sezary Syndrome; Skin Neoplasms | 2021 |
Disappearance of seborrheic keratoses following treatment with methotrexate.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Dermatologic Agents; Female; Humans; Keratosis, Seborrheic; Methotrexate; Mycosis Fungoides; Sezary Syndrome; Skin Neoplasms; Treatment Outcome | 2013 |
Sézary syndrome without erythroderma.
Topics: Administration, Topical; Adrenal Cortex Hormones; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Combined Modality Therapy; Dermatitis, Exfoliative; Female; Follow-Up Studies; France; Humans; Immunohistochemistry; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Photopheresis; Rare Diseases; Retrospective Studies; Risk Assessment; Sampling Studies; Sex Factors; Sezary Syndrome; Skin Neoplasms | 2015 |
Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a patient with Sézary syndrome treated by methotrexate.
Topics: Aged; Antimetabolites, Antineoplastic; Fatal Outcome; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Sezary Syndrome; Skin Neoplasms | 2016 |
[Cutaneous granular bacteriosis occurring in Staphylococcus aureus septicaemia].
Topics: Antimetabolites, Antineoplastic; Cutaneous Fistula; Dermatomycoses; Diagnosis, Differential; Female; Humans; Lung Abscess; Methotrexate; Middle Aged; Mycetoma; Sepsis; Sezary Syndrome; Staining and Labeling; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 2017 |
Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Cohort Studies; Disease-Free Survival; Female; Humans; Interferon-alpha; Male; Methotrexate; Middle Aged; Photopheresis; Retrospective Studies; Sezary Syndrome; Skin Neoplasms; Survival Rate; Tetrahydronaphthalenes; Treatment Outcome | 2008 |
Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
Topics: Aged; Azathioprine; B-Lymphocytes; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Mycosis Fungoides; Prednisone; Sezary Syndrome; Skin Neoplasms | 2011 |
Serum levels of CC chemokine receptor 4 and CXC chemokine receptor 3 ligands in CD8(+) Sézary syndrome.
Topics: Antimetabolites, Antineoplastic; CD8 Antigens; Chemokines; Humans; Male; Methotrexate; Middle Aged; Receptors, CCR4; Receptors, CXCR3; Sezary Syndrome; Skin Neoplasms | 2012 |
Methotrexate-induced lymphoproliferative disorder in a patient with Sézary syndrome.
Topics: Aged; Antimetabolites, Antineoplastic; Biopsy; Disease Progression; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphatic Diseases; Lymphoproliferative Disorders; Male; Methotrexate; Prognosis; Risk Factors; Sezary Syndrome | 2006 |
Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis.
Topics: Aged; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antirheumatic Agents; Humans; Infliximab; Lymphoma, Non-Hodgkin; Male; Methotrexate; Risk Factors; Sezary Syndrome; Skin Neoplasms; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Treatment of Sézary syndrome with bexarotene after IFNalpha and methotrexate failure.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Bexarotene; Drug Resistance, Neoplasm; Fatal Outcome; Female; Humans; Immunologic Factors; Interferon-alpha; Methotrexate; Middle Aged; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes | 2008 |
[Low-dosage methotrexate in pre-Sézary syndrome].
Topics: Aged; Biopsy; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Injections, Intravenous; Male; Methotrexate; Sezary Syndrome; Skin | 1999 |
[Sézary syndrome showing a stable clinical course for more than four years after oral administration of etoposide and methotrexate].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Methotrexate; Middle Aged; Sezary Syndrome; Skin Neoplasms; Time Factors | 2000 |
Low-dose methotrexate for the Sézary syndrome.
Topics: Adolescent; Adult; Aged; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Sezary Syndrome; Survival Rate | 1989 |